New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareEnclomiphene vs Ipamorelin

Enclomiphene vs Ipamorelin

Side-by-side comparison of key properties, dosing, and research.

GLP-1 / Weight Loss Agonists
Enclomiphene
Growth Hormone Peptides
Ipamorelin
Summary
Enclomiphene is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) that stimulates endogenous testosterone production by blocking estrogen negative feedback on the hypothalamus and pituitary. Unlike TRT, it restores testosterone while preserving or increasing sperm production and testicular volume.
Ipamorelin is a selective GHRP (growth hormone releasing peptide) and one of the cleanest GH secretagogues available. It selectively stimulates GH release without significantly raising cortisol, prolactin, or appetite — making it ideal for long-term use and anti-aging protocols.
Half-Life
5-7 days (long half-life; accumulates)
2 hours
Admin Route
Oral
SubQ
Research
Typical Dose
12.5-25 mg per day
100–300 mcg
Frequency
Once daily or every other day
Once to twice daily
Key Benefits
  • Restores testosterone to normal range without exogenous androgen administration
  • Preserves or increases sperm production and fertility
  • Maintains testicular volume (unlike TRT which causes testicular atrophy)
  • LH and FSH levels rise, indicating intact HPG axis function
  • Option for hypogonadal men desiring fertility
  • Oral administration (no injection required)
  • Increases lean muscle mass
  • Enhances fat loss
  • Improves recovery time
  • Strengthens bones and joints
  • Better sleep quality and REM sleep
  • Enhanced skin elasticity
  • Minimal impact on hunger or cortisol
  • No cortisol or prolactin spike
  • Clean GH release suitable for long-term protocols
Side Effects
  • Visual disturbances (rare but class-related SERM effect)
  • Mood changes or irritability
  • Hot flashes
  • Elevated estradiol in some users
  • +2 more
  • Injection site irritation
  • Temporary water retention (mild)
  • Possible hunger increase (milder than GHRP-6)
  • Numbness or tingling in extremities (rare)
Stacks With